Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Importance of thiopurine S-Methyltransferase gene polymorphisms for prediction of azathioprine toxicity.

Kolorz M, Bartosova L, Hosek J, Dvorackova D, Chylkova A, Zboril V, Batovsky M, Bartos M.

Neuro Endocrinol Lett. 2009;30 Suppl 1:137-42.

PMID:
20027160
2.

Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine.

Clunie GP, Lennard L.

Rheumatology (Oxford). 2004 Jan;43(1):13-8. Epub 2003 Oct 17. Review.

PMID:
14566029
3.

Clinical utility of thiopurine S-methyltransferase genotyping.

Corominas H, Baiget M.

Am J Pharmacogenomics. 2004;4(1):1-8. Review.

PMID:
14987117
4.

Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.

Gearry RB, Barclay ML.

J Gastroenterol Hepatol. 2005 Aug;20(8):1149-57. Review.

PMID:
16048561
5.

Utility of assessing thiopurine S-methyltransferase polymorphisms before azathioprine therapy.

Cabaleiro T, Roman M, Gisbert JP, Abad-Santos F.

Curr Drug Metab. 2012 Nov;13(9):1277-93. Review.

PMID:
22493988
6.

Pancytopenia related to azathioprine--an enzyme deficiency caused by a common genetic polymorphism: a review.

Anstey A, Lennard L, Mayou SC, Kirby JD.

J R Soc Med. 1992 Dec;85(12):752-6. Review. No abstract available.

7.

Thiopurine toxicity.

de Wit KL, White BE, Goldsmith D.

Br J Hosp Med (Lond). 2013 Oct;74(10):C153-6. Review. No abstract available.

PMID:
24273766

Supplemental Content

Support Center